Methylprednisolone Shows No Clear Benefit for FA Patients in Pilot Trial – Friedreich’s Ataxia News

Treatment with methylprednisolone, an anti-inflammatory medication, had no evident benefit in children and adults with Friedreich’s ataxia (FA) enrolled in a pilot clinical trial conducted at the Children’s Hospital of Philadelphia (CHOP).

Read more at:

Font Resize